Roger P. Smith, M.D. is a clinical advisor for PDC providing specific expertise in the development of the company’s primary dysmenorrhea program. Dr. Smith is currently a Professor and Vice Chairman of the Department of Obstetrics and Gynecology at the University of Missouri-Kansas City, Truman Medical Centre where he is also an attending physician. Dr. Smith has a special interest in primary dysmenorrhea and has been instrumental in the clinical development of compounds such as anti-inflammatory agents for the treatment of this condition.

Dr. Smith is also an expert in the analysis of intrauterine pressure data used to evaluate the effect of agents in the treatment of dysmenorrhea. Dr. Smith is recognized as an expert in the treatment of dysmenorrhea and has given presentations at national, regional and state meetings on this disorder and written numerous peer-reviewed articles and therapeutic area reviews as well as book chapters on the subject. For the past two years Dr. Smith has presented “Cramping Your Style? New options and concepts in dysmenorrhea therapy,” at the Annual Clinical Conference of The American College of Obstetricians and Gynecologists.

David Olson, PhD acts a scientific advisor for the company's preclinical and clinical programs. He is Director, Perinatal Research Centre and Professor, Depts. Obstetrics & Gynaecology, Physiology and Pediatrics at the University of Alberta. His research focus is exploring the role of prostaglandins in the control of birth in women. Dr. Olson’s laboratory also studies the various genetic, physiological and environmental factors that contribute to both term and preterm labour. His long-term objective is to translate basic science discoveries to practical therapeutic applications to improve the health of mothers and babies. Dr. Olson has conducted and published studies on two of the company's peptides in animal models of preterm birth.

Professor and Specialist in Gynaecology at the AKH in Vienna.

Dr. Singer received his medical degree from the University of Innsbruck in 1990. He also received a Master of Public Health degree from Harvard Medical School. Dr. Singer has a special interest in breast cancer and has published numerous scientific articles in this area. He has acted as an Expert Evaluator for the European Commission in Brussels and has been the recipient of numerous research awards.

Head of the Preterm Labour department at the AKH in Vienna

Professor Helmer graduated from the University of Vienna in 1987. Following a Fellowship with Anna-Riitta Fuchs at Cornell University Medical College, New York, he completed his residency at the University of Vienna, General Hospital. Professor Helmer has been a Senior Physician in the Department of Obstetrics and Gynaecology at the University of Vienna since 1999. He is an experienced clinical researcher in preterm labour and has published numerous scientific papers and presented his findings at international congresses on his research in preterm labour including clinical studies with atosiban.